This was the stock's fourth consecutive day of losses.

Valued at a market cap of $57.1 billion, Becton, Dickinson and Company (BDX) is a global medical technology company that ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has launched a new advanced ...

Shares of Becton Dickinson & Co. BDX advanced 1.34% to $201.78 Friday, on what proved to be an all-around favorable trading ...

Orange County’s medical device industry remains highly active, despite the appearance of slowing growth on the surface.

Stephen “Buck” Daniel said his client, retired truck driver Gary Walker, developed non-Hodgkin lymphoma and went through 10 cycles of chemotherapy and a stem cell transplant because of his “massive” ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted ...

Becton, Dickinson and Company had a return on equity of 15.74% and a net margin of 8.47%. On average, research analysts predict that Becton, Dickinson and Company will post 14.43 EPS for the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Barclays analyst Matt Miksic maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price target of $165.00.